Guidelines on the details of the various categories of variations
ANNEX
B.I.b) Control of active substance
B.I.c) Container closure system
B.I.e) Design Space and post-approval change management protocols
B.II.a) Description and composition
B.II.d) Control of finished product
B.II.e) Container closure system
B.II.g) Design Space and post approval change management protocol
B.II.h) Adventitious Agents Safety
B.V. Changes to a marketing authorisation resulting from other regulatory procedures
C. Safety, efficacy, pharmacovigilance changes
C.I Human and veterinary medicinal products
This Project is a comprehensive resource designed for navigating the complexities of pharmaceutical regulations in the European Union. This collection simplifies the rules around variations, making it easier for professionals to understand what changes can be made to registered medicines.
Contact
admin@variations-guidelines.eu
